drugset / Trial / NCT01095276
Impact of Nebulized Dornase Alpha on Mechanically Ventilated Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The investigators hypothesized that dornase alpha, administered twice a day (BID) by in-line nebulizer, would improve oxygenation, compliance, and time to extubation in adult patients receiving mechanical ventilation.
Timeline
- Start
- 2005-11
- Primary completion
- 2006-01
- Completion
- 2006-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | dornase alfa | Protein / enzyme biologic | 2.5 mg | Other |